年収1,600万円以上／創薬・テクニシャンの求人・転職情報

＜仕事の魅力＞
次世代型の細胞治療・遺伝子治療製品の創薬開発について、今後2～3年で米国IND申請、Phase1/2という、創薬ベンチャーでも最もダイナミックな開発フェーズを経験でき、キャリアアップを図ることができます。

＜仕事内容＞
ヒト造血幹細胞を利用した細胞治療・遺伝子治療のCMC業務（直近ではFDAへのIND申請）に携わっていただきます。
具体的には、ご経験やスキル等に応じて主に以下の業務の中からいくつかを担当いただきます。
・CMC規制業務（製造工程定義、SOP等文書化、QC、Comparability、GMP対応、IND申請関連等）
・海外委託先（CDMO等）の管理とマネジメント、トラブルシューティング（米国との英語でのやり取り）
・社外パートナーとの窓口業務
・CMCスタッフのマネジメント業務
＊以下の実験業務は必要に応じた支援やマネジメント
・ヒト細胞を用いた分離、培養、解析等のin vitro実験及び付随した業務（計画の策定とデータレビュー・解釈含む）
・ヒト細胞を用いた細胞培養法・製造法のスケールアップ実験（上記に同じ）

仕事内容：
ご本人の希望やこれまでの経験・スキルに応じて以下のような研究に取り組んでいただきます。
・医薬品分子設計に必要な機械学習技術の開発
　（深層生成モデルを用いた分子生成、ベイズ最適化を用いた実験計画等）
・機械学習技術を用いた創薬プロジェクトの推進"

You will:
・Develop machine learning technology for drug design, e.g., molecular generation using deep generative models and experimental design based on Bayesian optimization.
・Drive drug discovery projects exploitng machine learning technology

OBJECTIVES/PURPOSE

Work as part of a multi-disciplinary team of computational chemists, medicinal chemists, structural biologists, data scientists, pharmacologists and biologists and provide computational expertise to advance drug discovery projects.

Contribute to drug discovery efforts across various modalities including small molecules, PROTACs, RNA inhibitors, peptides, and more.

Implement and execute innovative computational methodologies and tools such as AI, free energy, and cheminformatics approaches to support drug discovery efforts.

ACCOUNTABILITIES

Principal Scientist

Independently design and execute computational strategies for drug discovery projects

Contribute as a key scientific expert within one or more project teams

Develop and apply innovative computational methodologies to solve project challenges

Influence project decisions through data-driven insights

Mentor junior scientists and contribute to scientific excellence



Associate Director

Provide scientific and strategic leadership across multiple drug discovery projects

Shape computational chemistry strategies and influence portfolio-level decisions

Drive adoption of emerging technologies (e.g., AI/ML, generative chemistry) across projects

Act as a thought leader to project teams and senior stakeholders

Influence cross-functional teams without direct line management authority

Mentor and elevate scientific capabilities across the organization

（雇入れ直後）
Oncology Research-Focused Scientific Engagement & Strategic Communications (Japan Support)
・Support the development of scientific narratives for early-stage oncology assets in partnership with Japan and global Oncology Research leads, ensuring alignment with the broader global scientific strategy and corporate narrative.
・Execute strategic scientific messaging for oncology assets from drug discovery through Proof of Concept (POC), with a focus on relevance for the Japan research environment and scientific community.
・Provide tactical support to global and regional AMTs on early data dissemination plans, ensuring alignment with asset development and communication strategies for the Japan region.
・Partner with Japan Corporate Communications to integrate early-stage scientific messaging into regional external engagement strategies, ensuring alignment with global guidance.
・Collaborate with global and regional Scientific Publications teams to align on scientific communication platforms, ensuring a unified strategy for the early oncology pipeline.
・Support the integration of early-phase scientific communication with data-driven insights by liaising with QSEQ’s biostatistics, RWE, and epidemiology teams to contribute to evidence-backed communication materials.

Oncology Early Pipeline Publications & Content Strategy (Regional Execution)
・Support the implementation of global publication plans to ensure early-phase oncology assets are strategically positioned in regional and global scientific discourse.
・Assist in developing and executing publication strategies in collaboration with Subject Matter Experts (SMEs) within Japan R&D for early-phase pipeline publications.
・Leverage established global scientific platforms to enhance publications and optimize content for potential re-use in regional contexts.
・Ensure regional publication activities align with evolving scientific data and global early clinical development priorities.

Content Development & Scientific Communications Support
・Develop and adapt centralized scientific content for early-phase oncology assets to support regional Medical Information and Medical Education functions in Japan.
・Support Japan Medical Information content review for early pipeline scientific accuracy and consistency.
・Assist in guiding digital publication enhancements and publication extenders for early-phase oncology assets in the region.

Cross-Functional Collaboration & Stakeholder Engagement
・Ensure close collaboration with Japan and global Scientific Publications teams while maintaining a distinct focus on early-stage asset communications.
・Engage with Japan clinical, regulatory, and research teams to ensure that early-phase scientific insights are strategically communicated and aligned across functions.
・Represent the Japan early scientific engagement activities in internal discussions, contributing to strategic alignment between regional and global pipeline development efforts.

This position reports to an Executive Director.
This position is an individual contributor role.
This position is a hybrid position.
This position is part of the Quantitative Sciences and Evidence Generations group. Cell and Gene Therapy & Biopharma, or Exploratory statistics in SRS.

（変更の範囲）
会社内での全ての業務

【業務内容】
がん免疫の治療と幹細胞治療の研究をお任せします。
短期的な目標としては、現在既に活用している細胞治療のさらなる改善
長期的には、今後臨床で活用可能な、これまでにない新たな治療法の確立を目指しております。
・新しい細胞治療技術の研究/開発
・臨床応用に向けたデータ解析および報告書作成
・幹細胞/免疫細胞の培養/品質管理
・細胞培養技術の最適化（増殖効率向上、安全性評価など）
・フローサイト、PCRなどを用いた細胞解析
・臨床応用に向けたデータ解析および報告書作成

主な業務内容：
・組織または特定の治療領域の戦略的な科学的、治療的、および商業的ニーズを満たす事業開発機会を創出する。
・リーダーシップと戦略構築
・プロジェクト管理：メディカルケミストリープロジェクトの設計、実行、および管理を監督し、タイムリーな進捗と高品質な成果を確保する。
・チーム開発：社内の毛ミスとチームを指導・育成し、協力的で革新的な職場環境を醸成する。
・他部門との横断的なコラボレーションの推進

iPS細胞を活用した再生医療の研究開発に幅広く従事いただきます。

がん免疫の治療と幹細胞治療の研究をお任せします。
短期的な目標としては、現在既に活用している細胞治療のさらなる改善
長期的には、今後臨床で活用可能な、これまでにない新たな治療法の確立を目指しております。
・新しい細胞治療技術の研究/開発
・臨床応用に向けたデータ解析および報告書作成
・幹細胞/免疫細胞の培養/品質管理
・細胞培養技術の最適化（増殖効率向上、安全性評価など）
・フローサイト、PCRなどを用いた細胞解析
・臨床応用に向けたデータ解析および報告書作成

仕事内容：
創薬研究プロジェクト加速のため、現場研究者との議論を通じて研究データ・ナレッジ利活用における本質的・潜在的な課題やニーズを同定し、最新のデジタルIT技術を活用して解決に導く。
それらを実現するための中長期戦略を立案し、研究員および部門マネジメントとの議論を通じた組織的意識改革および戦略遂行を実践することで意思決定サイクルを加速する。
将来的なマネジャーもしくはプロフェッショナル職候補として、多様なメンバーを巻き込みプロジェクト推進をリードするとともに、周囲のロールモデルとなり継続的な組織のケイパビリティ向上に貢献する。

（Purpose）

Leveraging a proven track record of leading at least 3 discovery programs to clinic, The Global Therapeutic Research Lead (G-TRL) is a pipeline critical strategic leader responsible for driving Research projects to the clinic. The individual will sit on the Neuroscience Drug Discovery Unit (NS DDU) Leadership Team.
Leader for at least one or more of Takeda’s top priority oligonucleotide projects with substantial clinical and commercial potential with a clear accelerated path to the clinic.
You will provide mentorship to team members to elevate enterprise thinking and capabilities of our drug discovery talent across the global Research function.
As project lead, the G-TRL builds a connected view of the project within the Neuroscience TA strategy and treatment paradigm and can represent all core expertise at depth and align with stakeholders and sponsors across the organization including Research, Clinical Development and Commercial stakeholders and executive level governance committees.
G-TRLs are responsible for creating the medicine vision, early asset strategy and managing multiple external partnerships that accelerate delivery of the project.
G-TRLs will establish smart, fast, and critical path minded practices for groups, including integrating new strategies and competitive industry ways of working.
G-TRL will advise on the continuous infusion of new Research projects aligned to strategy to generate a sustainable Research Engine generating a steady flow of high-quality INDs every year.

（Accountabilities）

Lead and manage one or more ‘Top 10’ drug discovery oligonucleotide projects, overseeing the entire drug discovery process from target identification to preclinical development. (Top 10 projects are well validated targets that are focused on strategically aligned modalities with substantial clinical and commercial potential)
Responsible for the articulation and ownership of the project strategy, developed in partnership with internal stakeholders.
Contribute to strategy for future portfolio investment, particularly within the Inflammation and Immunology area including advising on which projects should be Top 10 projects.
Evaluate and prioritize potential drug candidates based on scientific, medical, and commercial considerations.
Represent all core expertise for project.
Partner with Clinical and Translational teams to refine asset strategy.
Ensure alignment to the therapeutic area strategy (i.e., Clinical Development).
Understand and align with commercial team for asset commercial value within the Neuroscience Therapeutic Area (NS TA).
Provide guidance and mentorship to global project team members, stimulating enterprise thinking and fostering their professional growth and development.
Mentor future and more junior project leads and elevate drug discovery capability across Research.
Collaborate with cross-functional teams and partners (e.g., DMPK, Pharmaceutical Sciences) within and outside Takeda to drive project delivery.
Pipeline and enterprise impact through effective partnering with multiple internal and external collaborators.
Provide strategic, process, and operational leadership for successful Top 10 Project delivery.
Foster a culture of innovation and scientific excellence within the matrixed drug discovery team, promoting collaboration, knowledge sharing, and continuous learning.
Become a world leading scientific expert in the projects you lead.
Oversee the design and execution of experiments, data analysis, and interpretation to enable decision-making and optimize drug discovery efforts.
Stay abreast of the latest advancements in drug discovery, emerging technologies, and industry trends, applying this knowledge to enhance drug discovery strategies.
Build and maintain relationships with key stakeholders, including academic institutions, research organizations, and industry partners inclusive of serving on joint external governance committees across the globe.
Represent Takeda externally for the Neuroscience Drug Discovery Unit and play a key role in evaluating external opportunities, serving as an effective ambassador for Takeda’s global business development brand.

【具体的な職務内容】
・創薬プロジェクトの中で Digital Unit 部門の代表者として国内外のクライアント、社内外のステイクホルダーと議論/連携/調整を通じて、プロジェクト推進に必要なAI技術の提案・実装・適用を行う（50%）。
・半年後～1年後に必要となるであろうAI技術の研究開発を行う（50%）。

トランスフェリン受容体に対する抗体に治療効果をもたらすオリゴ核酸を繋げ、既存の方法では送達できない臓器に核酸を届ける、次世代のミサイル療法の研究開発を担っていただける方を募集いたします。

■主な業務内容
当社独自のプラットフォーム技術である核酸デリバリーシステムを基盤とした創薬研究をご担当いただきます。技術習得後は、テーマ立案・推進などのアイディアや、共同研究など、多様な研究活動に主体的に関わっていただきたく思います。
(具体的には、抗体の精製、抗体―核酸コンジュゲートの調製・精製、プラスミド構築、細胞培養などの実験業務に加えて、社外研究機関との連携や補助金申請などの事務業務など)